Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. ' Osimertinib ' ) Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung Cancer

Conditions: Leptomeningeal Metastasis Interventions: Drug: Osimertinib; Drug: Pemetrexed Sponsors: Guangzhou Medical University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials